Seeing Is Believing
Currently, out of the existing stock ratings of Roy Buchanan - 32 which are a Buy (100%)
Analyst Roy Buchanan works at JMP and is covering the Healthcare sector with 57 price targets and ratings displayed on 8 stocks.
Roy Buchanan's average stock forecast success ratio is 37.66% with an average time for price targets to be met of 88.43 days.
Most recent stock forecast was given on ENTA, Enanta Pharmaceuticals at 21-Nov-2023.
Analyst best performing recommendations are on ENTA (ENANTA PHARMACEUTICALS).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 11/8/2021. The price target of $77 was fulfilled within 11 days with a profit of $17.24 (18.29%) receiving and performance score of 16.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
10
$4.44 (79.86%)
20
3 months 14 days ago
2/3 (66.67%)
$-1.82 (1.91%)
19
Buy
24
$18.76 (358.02%)
34
7 months 9 days ago
0/4 (0%)
$21.69 (222.23%)
Buy
9
$3.44 (61.87%)
10 months 26 days ago
1/1 (100%)
$-1.36 (-13.13%)
31
Sell
47
2 years 7 months 9 days ago
1/1 (100%)
$-81.95 (-63.55%)
295
Which stock is Roy Buchanan is most bullish on?
Which stock is Roy Buchanan is most reserved on?
What Year was the first public recommendation made by Roy Buchanan?